Doing more with less at large pharmaceutical companies

Entire pathology departments at large pharmaceutical companies are being asked to change how they do business in this new decade. Capital spending is tighter, and obtaining adequate headcount to support the work of the pathologists is even more difficult. At Flagship we work with multiple large pharmaceutical companies, serving in a variety of ways to supplement the work they do in house. This ranges from advanced training in image analysis, to overload capacity in scanning, image analysis, and pathology review. For some large customers we host data virtually and securely, as a cloud computing model, for others we complete work and send results back in-house for review and storage.

Using digital pathology takes time to learn and scale-up efficiently. Our pathologists work on image analysis every day, and we have learned a lot from this experience, which we can share with your pathology teams.